Consonance Capital Management LP Vanda Pharmaceuticals Inc. Transaction History

Consonance Capital Management LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$12.27 - $15.79 $44.5 Million - $57.3 Million	-3,626,545 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$13.37 - $18.85 $8.45 Million - $11.9 Million	-631,813 Reduced 14.84%	3,626,545 $51.1 Million
Q1 2019 May 15, 2019	SELL	$17.59 - $31.05 $7.04 Million - $12.4 Million	-400,401 Reduced 8.59%	4,258,358 $78.4 Million
Q4 2018 Feb 14, 2019	BUY	$18.97 - $31.47 $4.08 Million - $6.77 Million	215,000 Added 4.84%	4,658,759 $122 Million
Q3 2018 Nov 14, 2018	SELL	$18.25 - $23.0 $3.02 Million - $3.8 Million	-165,284 Reduced 3.59%	4,443,759 $102 Million
Q2 2018 Aug 14, 2018	BUY	$13.95 - $19.15 $21.4 Million - $29.4 Million	1,536,768 Added 50.02%	4,609,043 $87.8 Million
Q1 2018 May 15, 2018	BUY	$14.05 - $20.2 $43.2 Million - $62.1 Million	3,072,275 New	3,072,275 $51.8 Million

161

45.2M

165K

33.6K

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $265M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

Get notified when there are updates to the investment portfolio of Consonance Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Consonance Capital Management LP with notifications on news.